Health

Results: 805-816 of 10116

Sales of Leqembi® totaled 29.3 billion yen in the second quarter 2026

Opzelura® (ruxolitinib) Cream Becomes First Steroid-Free Topical JAK Inhibitor Approved in the European Union for Adults with Moderate Atopic Dermatitis

Ping An Ranks 48th on 2026 Fortune Global 500 List, Marking 17th Consecutive Year on List

PK MED Strengthens Its Strategic and Scientific Governance to Support the Development of Its Therapeutic Micro-implants

VARON Celebrates Brand Appreciation Days With Trusted Oxygen Solutions Across Europe

Photocure ASA: Results for the second quarter of 2026

PR Newswire associated0

Ozelle Launches O-Cyte 1 at ADLM 2026, Marking a New Step in AI-Powered Hematology

PR Newswire associated0

Nitinotes Announces First Study Procedures at Orlando Health in the EASE™ IDE Trial

PR Newswire associated0

Dasher Neuroscience Completes Patient Enrollment in Phase 2 Global Clinical Trial of Lead AI Drug Candidate YA-101 for Multiple System Atrophy (MSA)

B-Secur and CSEM Partner to Bring Clinically-Validated Heart Monitoring to Health Wearables

ICON announces multi-year collaboration with Anthropic to bring frontier AI to clinical trials

Alkermes plc Reports Second Quarter 2026 Financial Results